El Miedany, Yasser http://orcid.org/0000-0002-4543-692X
El Gaafary, Maha http://orcid.org/0000-0002-3948-3826
GadAllah, Naglaa
Mansour, Mona
Fathy, Nihal
Hassan, Waleed http://orcid.org/0000-0002-3238-6804
Mortada, Mohamed http://orcid.org/0000-0002-7198-9878
Galal, Salwa http://orcid.org/0000-0002-5010-2959
Eissa, Mervat http://orcid.org/0000-0001-7999-3401
Tabra, Samar Abdelhamed http://orcid.org/0000-0001-6414-5602
Foad, Nermeen http://orcid.org/0000-0002-6461-4939
Ali, Rehab
Medhat, Basma http://orcid.org/0000-0001-6944-6367
El Olemy, Gehan http://orcid.org/0000-0001-5196-8300
Adel, Yasmin http://orcid.org/0000-0002-2798-2353
Ghaleb, Rasha http://orcid.org/0000-0003-4283-9034
El-Latif, Eiman Abd http://orcid.org/0000-0003-1629-3154
Saber, Sally http://orcid.org/0000-0001-8162-4699
Elkaraly, Nourhan
Abu-Zaid, Mohammed Hassan http://orcid.org/0000-0001-8436-8598
Article History
Received: 15 February 2022
Accepted: 21 April 2022
First Online: 1 June 2022
Declarations
:
: This study was performed in accordance with the Helsinki Declaration. This was a multistep process which followed the “Clinical, Evidence-based, Guidelines” (CEG) initiative protocol (ethical approval code: 34842/8/21, ethical board Tanta University) aiming at setting up an actionable clinical gold standard for Treat-to-Target management of rheumatic and bone diseases. As per the Egyptian national Ethical Committee regulations, verbal informed consent was required from all the participants included in the study. All the participants included in the study gave their verbal informed consent. All the participants were kept anonymous, in compliance with data protection regulations.
: Not applicable
: The authors declare that the corresponding author Mohammed Hassan Abu‑Zaid is Associate Editor in the Egyptian Rheumatology and Rehabilitation, while Mohammed Mortada and Yasser El Miedany are on the Editorial Board of the journal.